MIOGGI Magic Advanced Skin Essential Activator
- Manufacturer
- Colorpink R&D Inc.
- Effective date
- 2012-08-20
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:33:15
Label at a glance#
ProductMIOGGI Magic Advanced Skin Essential Activator
Active ingredientADENOSINE
Label structure8 sections
Label contents#
Full prescribing information#
ADENOSINE
INACTIVE INGREDIENT SECTION
Water, Methylsilanol mannuronate, Beta-glucan, Butylene glycol, Propanediol, PEG-60 hydrogenated castor oil, Morus alba root extract, Diospyros kaki leaf extract, Camellia sinensis leaf extract, Aloe barbadensis leaf extract, Dipotassium glycyrrhizate, Allantoin, Sodium hyaluronate, Adenosine, Sodium carbomer, Uncaria sinensis extract, Portulaca oleracea extract, Paeonia lactiflora root extract, Hamamelis virginiana(Witch hazel) bark/leaf/twig extract, Ginkgo biloba leaf extract, Citrus aurantium amara (Bitter orange) fruit extract, Rehmannia glutinosa root extract, Paeonia suffruticosa bark extract, Dryopteris crassirhizoma extract, Dryopteris filix-mas root extract, Cnidium officinale root extract, Cimicifuga racemosa root extract, Angelica acutiloba root extract, Macadamia ternifolia seed oil, Caprylic/capric triglyceride, Glycerin, PEG-5 rapeseed sterol, Cholesterol, Brassica campestris (Rapeseed) sterols, Beta-sitosterol, Saccharide isomerate, Hydrogenated lecithin, Ceramide 3, Choleth-24, Ceteth-24, Aronia melanocarpa fruit extract, Dextran, Polyglutamic acid, Creatine, Cetyl phosphate, Caprooyl tetrapeptide-3, Carthamus tinctorius (Safflower) seed extract, Disodium EDTA, Phenoxyethanol, Methylparaben, Proplyparaben, BHT, Fragrance
OTC - PURPOSE SECTION
for improving skin wrinkles
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
keep out of reach of the children
INDICATIONS & USAGE SECTION
Apply every morning and evening after cleansing.
Dispense a generous amount onto palm, gently pat and massage over face until fully absorbed
Dispense a generous amount onto palm, gently pat and massage over face until fully absorbed
WARNINGS SECTION
1. In case of having following symptoms after using this, you're advised to stop using it immediately. If you keep using it, the symptoms will get worse and need to consult a dermatologist.
A. In case of having problems such as red rash, swollenness, itching, stimulation during usage.
B. In case of having the same symptoms above on the part you put this product on by direct sunlight.
2. You are banned to use it on the part where you have a scar, eczema, or dermatitis.
3. Caution for treatment and keeping.
A. Tighten the lid after using it.
B. Keep it out of infants or children's reach.
C. Don't keep it in the place where the temperature is extremely hot or low and exposed to the direct sunlight.
A. In case of having problems such as red rash, swollenness, itching, stimulation during usage.
B. In case of having the same symptoms above on the part you put this product on by direct sunlight.
2. You are banned to use it on the part where you have a scar, eczema, or dermatitis.
3. Caution for treatment and keeping.
A. Tighten the lid after using it.
B. Keep it out of infants or children's reach.
C. Don't keep it in the place where the temperature is extremely hot or low and exposed to the direct sunlight.
DOSAGE & ADMINISTRATION SECTION
- for external use only
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| ADENOSINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d676a241-be05-4740-b3ee-1a5f2ed422d2 | Product name | 4 | 20180615 |
| dd8bd48f-20d6-43c7-b471-3ae872868afa | Product name | 3 | 20180125 |
| d41954ff-bc63-4b2c-aba0-9146707659d7 | Product name | 2 | 20151117 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 53009-2001-1 | 2019-11-27 | C162847 | 48780-1 | 9855d018-d919-cd31-e053-dbdaa90ab51a | Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 53009-2001-1 | MIOGGI Magic Advanced Skin Essential Activator | 125 mL in 1 BOTTLE, GLASS | LIQUID | 125 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 53009-2001 | MIOGGI MAGIC ADVANCED SKIN ESSENTIAL ACTIVATOR (ADENOSINE) LIQUID [COLORPINK R&D INC.] | 1 | Legacy NDC, 1 package rows | 20121011_7a0265cb-9475-4740-9dd4-5fe2005876c9.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ADENOSINE | ACTIVE INGREDIENT | K72T3FS567 | 1 | |
| ADENOSINE | ACTIVE MOIETY | K72T3FS567 | 1 | |
| .BETA.-SITOSTEROL | INACTIVE INGREDIENT | S347WMO6M4 | 1 | |
| ALLANTOIN | INACTIVE INGREDIENT | 344S277G0Z | 1 | |
| ALOE VERA LEAF | INACTIVE INGREDIENT | ZY81Z83H0X | 1 | |
| ANGELICA ACUTILOBA ROOT | INACTIVE INGREDIENT | 3W51R3EK30 | 1 | |
| ARONIA MELANOCARPA FRUIT | INACTIVE INGREDIENT | S935718Z2Q | 1 | |
| BITTER ORANGE OIL | INACTIVE INGREDIENT | 9TLV70SV6I | 1 | |
| BLACK COHOSH | INACTIVE INGREDIENT | K73E24S6X9 | 1 | |
| BUTYLATED HYDROXYTOLUENE | INACTIVE INGREDIENT | 1P9D0Z171K | 1 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| CAPROOYL TETRAPEPTIDE-3 | INACTIVE INGREDIENT | LZI0HJ3K2R | 1 | |
| CARTHAMUS TINCTORIUS SEEDCAKE | INACTIVE INGREDIENT | DHQ13F4N2W | 1 | |
| CERAMIDE 3 | INACTIVE INGREDIENT | 4370DF050B | 1 | |
| CETETH-24 | INACTIVE INGREDIENT | 0EV3Z43Y2I | 1 | |
| CETYL PHOSPHATE | INACTIVE INGREDIENT | VT07D6X67O | 1 | |
| CHOLESTEROL | INACTIVE INGREDIENT | 97C5T2UQ7J | 1 | |
| CHOLETH-24 | INACTIVE INGREDIENT | 5UE7I54O43 | 1 | |
| CNIDIUM OFFICINALE ROOT | INACTIVE INGREDIENT | 8S3OZD358J | 1 | |
| CREATINE | INACTIVE INGREDIENT | MU72812GK0 | 1 | |
| DEXTRAN 40 | INACTIVE INGREDIENT | K3R6ZDH4DU | 1 | |
| DIOSPYROS KAKI LEAF | INACTIVE INGREDIENT | Q71GF9OBNO | 1 | |
| DRYOPTERIS CRASSIRHIZOMA WHOLE | INACTIVE INGREDIENT | V3B80C759E | 1 | |
| DRYOPTERIS FILIX-MAS ROOT | INACTIVE INGREDIENT | C0ZK0RRF5X | 1 | |
| GINKGO | INACTIVE INGREDIENT | 19FUJ2C58T | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| GLYCYRRHIZINATE DIPOTASSIUM | INACTIVE INGREDIENT | CA2Y0FE3FX | 1 | |
| GREEN TEA LEAF | INACTIVE INGREDIENT | W2ZU1RY8B0 | 1 | |
| HYALURONATE SODIUM | INACTIVE INGREDIENT | YSE9PPT4TH | 1 | |
| HYDROGENATED SOYBEAN LECITHIN | INACTIVE INGREDIENT | H1109Z9J4N | 1 | |
| MACADAMIA NUT | INACTIVE INGREDIENT | Y5432RGW8N | 1 | |
| MEDIUM-CHAIN TRIGLYCERIDES | INACTIVE INGREDIENT | C9H2L21V7U | 1 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | 1 | |
| MORUS ALBA ROOT | INACTIVE INGREDIENT | CST1G9BZGD | 1 | |
| PAEONIA LACTIFLORA ROOT | INACTIVE INGREDIENT | 3Z3866YW6P | 1 | |
| PAEONIA SUFFRUTICOSA ROOT BARK | INACTIVE INGREDIENT | BUG255FE7X | 1 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| POLYOXYL 60 CASTOR OIL | INACTIVE INGREDIENT | VXP26NM2XX | 1 | |
| PORTULACA OLERACEA WHOLE | INACTIVE INGREDIENT | D5J3623SV2 | 1 | |
| PROPANEDIOL | INACTIVE INGREDIENT | 5965N8W85T | 1 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | 1 | |
| RAPESEED STEROL | INACTIVE INGREDIENT | B46B6DD20U | 1 | |
| REHMANNIA GLUTINOSA ROOT | INACTIVE INGREDIENT | 1BEM3U6LQQ | 1 | |
| SACCHARIDE ISOMERATE | INACTIVE INGREDIENT | W8K377W98I | 1 | |
| UNCARIA SINENSIS WHOLE | INACTIVE INGREDIENT | 69OQ216G2K | 1 | |
| WITCH HAZEL | INACTIVE INGREDIENT | 101I4J0U34 | 1 |
Products#
Every source-derived product name is available through these pages.
- MIOGGI Magic Advanced Skin Essential Activator
- ADENOSINE
- BUTYLENE GLYCOL
- PROPANEDIOL
- POLYOXYL 60 CASTOR OIL
- MORUS ALBA ROOT
- DIOSPYROS KAKI LEAF
- GREEN TEA LEAF
- ALOE VERA LEAF
- GLYCYRRHIZINATE DIPOTASSIUM
- ALLANTOIN
- HYALURONATE SODIUM
- UNCARIA SINENSIS WHOLE
- PORTULACA OLERACEA WHOLE
- PAEONIA LACTIFLORA ROOT
- WITCH HAZEL
- GINKGO
- BITTER ORANGE OIL
- REHMANNIA GLUTINOSA ROOT
- PAEONIA SUFFRUTICOSA ROOT BARK
- DRYOPTERIS CRASSIRHIZOMA WHOLE
- DRYOPTERIS FILIX-MAS ROOT
- CNIDIUM OFFICINALE ROOT
- BLACK COHOSH
- ANGELICA ACUTILOBA ROOT
- MACADAMIA NUT
- MEDIUM-CHAIN TRIGLYCERIDES
- GLYCERIN
- CHOLESTEROL
- RAPESEED STEROL
- .BETA.-SITOSTEROL
- SACCHARIDE ISOMERATE
- HYDROGENATED SOYBEAN LECITHIN
- CERAMIDE 3
- CHOLETH-24
- CETETH-24
- ARONIA MELANOCARPA FRUIT
- DEXTRAN 40
- CREATINE
- CETYL PHOSPHATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 53009-2001 | 53009-2001-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCERIN | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | OINTMENT / TOPICAL | 57 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CONCENTRATE / ORAL | 1800 mg | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRAMUSCULAR | 23 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | CREAM / TOPICAL | 3000 mg | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | GEL / TOPICAL | 463 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / NASAL | 140 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / IONTOPHORESIS | 168.1 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SUPPOSITORY / RECTAL | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | OINTMENT / OPHTHALMIC | 0.05 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | CREAM / VAGINAL | 22 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / AURICULAR (OTIC) | NA | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | GRANULE, FOR SUSPENSION / ORAL | 80 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | TABLET, CHEWABLE / ORAL | 0.14 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SHAMPOO / TOPICAL | 0.15 %w/w | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | AEROSOL, FOAM / TOPICAL | 4 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / ORAL | 100 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| CHOLETH-24 | CHOLETH-24 | 5UE7I54O43 | EMULSION / TOPICAL | 5 %w/w | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | GEL / TOPICAL | 8 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | LOTION / TOPICAL | 7 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / ORAL | 26208 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SHAMPOO / TOPICAL | 0.1 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 2.2 %w/v | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / INTRAVENOUS | 6 mg | ||
| CHOLESTEROL | CHOLESTEROL | 97C5T2UQ7J | INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS | 0.32 %w/v | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | CONCENTRATE / ORAL | 2.5 mg/5ml | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | CREAM / VAGINAL | 0.05 %w/w | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | OINTMENT / TOPICAL | 20 %w/w | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | LIQUID / TOPICAL | 0.1 %w/w | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SPRAY / NASAL | 0.2 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | ENEMA / RECTAL | 0.18 %w/v | ||
| HYDROGENATED SOYBEAN LECITHIN | HYDROGENATED SOYBEAN LECITHIN | H1109Z9J4N | TABLET / ORAL | 0.21 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | POWDER, FOR SUSPENSION / ORAL | 3390 mg/5ml | ||
| CHOLESTEROL | CHOLESTEROL | 97C5T2UQ7J | LOTION / TOPICAL | 20 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / INTRAVENOUS | 0.13 %w/v | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SUSPENSION / SUBCUTANEOUS | 0.02 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | TABLET, ORALLY DISINTEGRATING / ORAL | 1 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | JELLY / TOPICAL | 420 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | EMULSION / TOPICAL | 0.06 %w/w | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | INJECTION / INTRAVENOUS | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | 2000 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | DROPS / OPHTHALMIC | 0.01 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | ELIXIR / ORAL | 800 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | TABLET, EXTENDED RELEASE / ORAL | 0.17 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / EPIDURAL | 1 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | SOLUTION / ORAL | 5566 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | PASTE, DENTIFRICE / DENTAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SPRAY / TOPICAL | 0.8 %w/w | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | JELLY / TOPICAL | 180 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | SPRAY, METERED / SUBLINGUAL | 110 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / SOFT TISSUE | 0.02 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM, AUGMENTED / TOPICAL | 55 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2c6f47a0-36a3-4fd0-a303-d409f91031e0 | 7a0265cb-9475-4740-9dd4-5fe2005876c9 | 2012-08-20 | Warnings | 2c6f47a0-36a3-4fd0-a303-d409f91031e0 7a0265cb-9475-4740-9dd4-5fe2005876c9 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
